Suchergebnisse - "Held, Gerhard"

PubPharm (167)

41

Rationale and design of the 2 by 2 factorial design GnG-trial : a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML

enthalten in: Trials | 03 November 2021

von Jaramillo Segura, S. | Krisam, J. | Le Cornet, L. | +32

42

VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B‐cell lymphoma

enthalten in: European Journal of Haematology | 2021

von Kaddu‐Mulindwa, D. | Rosolowski, M. | Ziepert, M. | +6

43

Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)

enthalten in: Annals of hematology | 2020

von Zettl, F. | Ziepert, M. | Altmann, B. | +9

44

Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)

enthalten in: Annals of hematology | 2020

von Zettl, F. | Ziepert, M. | Altmann, B. | +9

45

Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)

enthalten in: Annals of hematology | 2020

von Zettl, F. | Ziepert, M. | Altmann, B. | +9

46

Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential

enthalten in: Cancer immunology, immunotherapy : CII | 2020

von Bewarder, M. | Held, G. | Thurner, L. | +12

47

Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma : Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

enthalten in: EJHaem | 2020

von Hohloch, K. | Ziepert, M. | Truemper, L. | +5

48

Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential

enthalten in: Cancer immunology immunotherapy | 2020

von Bewarder, M. | Held, G. | Thurner, L. | +12

49

Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential

enthalten in: Cancer immunology immunotherapy | 2020

von Bewarder, M. | Held, G. | Thurner, L. | +12

50

Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential

enthalten in: Cancer immunology immunotherapy | 2020

von Bewarder, M. | Held, G. | Thurner, L. | +12